Interpace Pharma Solutions Announces New Capability in Spatial Biology/Precision Oncology Services May 17, 2021
Interpace Biosciences to Explore Strategic Alternatives for Maximizing Shareholder Value Apr 22, 2021
Interpace Biosciences Announces New PLA Code and Medicare Reimbursement Increase for Proprietary Thyroid Assay, ThyGeNEXT® Apr 5, 2021
Interpace Biosciences Announces Full Year and Fourth Quarter 2020 Financial and Business Results Mar 31, 2021
